INOVIQ (ASX:IIQ) Insider Peter Gunzburg Acquires 100,000 Shares

INOVIQ Ltd (ASX:IIQ) insider Peter Gunzburg acquired 100,000 shares of INOVIQ stock in a transaction on Thursday, February 19th. The shares were bought at an average price of A$0.33 per share, with a total value of A$33,000.00.

INOVIQ Price Performance

The company has a market capitalization of $47.40 million, a P/E ratio of -6.02 and a beta of 2.04. The company has a quick ratio of 9.52, a current ratio of 7.07 and a debt-to-equity ratio of 2.02.

About INOVIQ

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample. Its cancer diagnostic pipeline includes blood tests in development for ovarian, breast, and other cancers.